【4583】カイオムバイオ
創薬。抗体作製技術。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023.12 | 2024/02/13 | 実 | 682 | - | - | - | -1,205 | - | - | - | -1,217 | - | - | - | -1,220 | - | - | - |
2022.12 | 2023/02/14 | 実 | 630 | - | - | - | -1,258 | - | - | - | -1,243 | - | - | - | -1,242 | - | - | - |
2021.12 | 2022/02/14 | 実 | 712 | - | - | - | -1,334 | - | - | - | -1,329 | - | - | - | -1,479 | - | - | - |
2020.12 | 2021/02/09 | 実 | 480 | - | - | - | -1,283 | - | - | - | -1,291 | - | - | - | -1,293 | - | - | - |
2019.12 | 2020/02/14 | 実 | 447 | - | - | - | -1,401 | - | - | - | -1,410 | - | - | - | -1,403 | - | - | - |
2018.12 | 2019/02/14 | 実 | 212 | - | - | - | -1,539 | - | - | - | -1,533 | - | - | - | -1,533 | - | - | - |
2017.12 | 2018/02/14 | 実 | 259 | - | - | - | -887 | - | - | - | -883 | - | - | - | -882 | - | - | - |
2016.12 | 2017/02/14 | 実 | 252 | - | - | - | -1,042 | - | - | - | -1,047 | - | - | - | -1,491 | - | - | - |
2015.12 | 2016/02/12 | 実 | 280 | ↑ | +10.2% | -58.2% | -1,269 | ↑ | +10.1% | +10.1% | -1,253 | ↑ | +10.9% | +34.8% | -1,282 | ↑ | +10.8% | +33.3% |
2015.12 | 2015/11/12 | Q3予 | 254 | ↓ | -62.1% | -62.1% | -1,412 | - | - | - | -1,407 | ↑ | +26.8% | +26.8% | -1,437 | ↑ | +25.2% | +25.2% |
2015.12 | 2015/02/13 | 当初予 | 670 | - | - | - | - | - | - | - | -1,923 | - | - | - | -1,921 | - | - | - |
2014.12 | 2015/02/13 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2014.12 | 2014/11/14 | Q2予 | 277 | → | 0.0% | -19.0% | -907 | → | 0.0% | +13.0% | -907 | → | 0.0% | +12.9% | -891 | → | 0.0% | +14.6% |
2014.12 | 2014/10/30 | 修正予 | 277 | ↓ | -19.0% | -19.0% | -907 | ↑ | +13.0% | +13.0% | -907 | ↑ | +12.9% | +12.9% | -891 | ↑ | +14.6% | +14.6% |
2014.12 | 2014/08/14 | Q1予 | 342 | - | - | - | -1,043 | - | - | - | -1,041 | - | - | - | -1,043 | - | - | - |
2014.03 | 2014/03/31 | 当初予 | 435 | - | - | - | - | - | - | - | -689 | - | - | - | -739 | - | - | - |